TOKYO: Toshiba plans to split into three companies as early as 2023, aiming to make the performance and growth strategy of each sector clearer, the Nikkei business daily reported on Tuesday (Nov ... ( read original story ...)
Toshiba to split business into three: report
Toshiba plans to split into three companies as early as 2023, a report said Tuesday, after a series of crises at the firm including the ouster of the board's chairman and a contentious buyout ... ( read original story ...)
Report: Japan’s Toshiba to split business into three
Toshiba plans to split into three companies as early as 2023, aiming to make the performance and growth strategy of each sector clearer, the Nikkei business daily reported Tuesday. The Japanese firm ... ( read original story ...)
Japan Data Due On Tuesday
Japan is scheduled to release a numbers of reports on Tuesday, headlining a modest day for Asia-Pacific economic activity. On tap are ... ( read original story ...)
Coronavirus: Japan reopens to business travel, students; Australians search for fake vaccination certificates
Singapore begins quarantine-free travel for vaccinated travellers from Australia and Switzerland, and Australia starts rolling out vaccine booster shots. ( read original story ...)
Hotel Keihan Chain selects Sabre as its new technology partner to expand its global footprint and aid tourism industry recovery in Japan
Sabre Corporation (NASDAQ: SABR), a leading software and technology company that powers the global travel industry, today announced a new strategic partnership with Osaka -headquartered Hotel Keihan ... ( read original story ...)
NTT Global, Tokyo Century expand data centre business in India
Japans NTT Corp., NTT Global Data Centers Corp. and Tokyo Century Corp. are expanding their Indian data centres business to the Navi Mumbai area. ( read original story ...)
Business arrivals welcome eased entry restrictions
Business travelers who arrived at Narita Airport near Tokyo on Monday say they welcome Japan's easing of coronavirus entry restrictions. ( read original story ...)
Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance Its CMO Business
Meiji Seika Pharma announces that construction of a new manufacturing facility at Adcock Ingram in India has been decided to enhance its CMO business. ( read original story ...)
Japan starts accepting requests for eased Covid quarantine
TOKYO: Japan's government started on Monday accepting applications for sharply reduced Covid-19 quarantine periods for vaccinated business travellers, ending a ban in principle on entry by ... ( read original story ...)
Japan to reopen borders to business, student tourists
Japan will take its first step in reopening the country to tourism on 8. Business and students will be allowed to enter the country, though they must provide proof of having been fully vaccinated, ... ( read original story ...)
Coronavirus: Japan reopens to business travel, students; Singapore launches Australia, Switzerland travel lanes
Singapore begins quarantine-free travel for vaccinated travellers from Australia and Switzerland, and Australia starts rolling out vaccine booster shots. ( read original story ...)
Japanese borders, closed since Jan., to reopen for business, students
Business and students will be allowed to enter the country, though they must provide proof of having been fully vaccinated. Eligible tourists will include business travelers, as well as foreign ... ( read original story ...)
Japan reduces quarantine to three days for vaccinated business travellers
As reported by The Asahi Shimbun, the government has officially reduced quarantine time for fully vaccinated business travellers coming into Japan to just three days (down from ten days). The relaxed ... ( read original story ...)
Japan starts accepting requests for eased COVID quarantine rule
Japan's government started on Monday accepting applications for sharply reduced COVID-19 quarantine periods for vaccinated business t ... ( read original story ...)
Japan’s Daiichi Sankyo to make mRNA vaccine pillar of business
Japanese drugmaker Daiichi Sankyo is racing to develop Japan's own messenger RNA vaccine, aiming for release by the end of next year, as CEO Sunao Manabe looks beyond COVID to make the technology a ... ( read original story ...)